IT   EN

Ultimi tweet

Video FDA: Cystic Fibrosis Drug

The drug Kalydeco has been approved to treat patients with one of the mutations that cause cystic fibrosis. FDA's Stephen Spielberg, M.D., Ph.D, tells how this targeted treatment represents how personalized medicine will revolutionize health care.